Siemens Healthineers, AiM team up; Procept completes study enrollment

Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept ...

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: ...

Robot-assisted simple prostatectomy, laser enucleation both safe for large-volume benign prostatic hyperplasia

Both robot-assisted simple prostatectomy (RASP) and laser enucleation of the prostate (LEP) are safe and effective surgical options for large-volume benign prostatic hyperplasia (BPH), according to a ...
The New England Journal of Medicine

Perioperative Apalutamide in High-Risk Localized Prostate Cancer

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We conducted a ...
Healio

Imfinzi combination snags FDA approval for high-risk non-muscle invasive bladder cancer

The FDA has approved an immunotherapy combination therapy for adult patients with Bacillus Calmette-Guérin-naive, high-risk ...
Cure Today

FDA Approves Imfinzi Plus BCG for High-Risk Bladder Cancer

Disease-free survival improved with durvalumab plus BCG induction/maintenance versus BCG alone, reducing recurrence/progression/death risk (HR 0.68; p=0.0154) with median DFS not reached. Eligibility ...
Out

Ballmaxxing: the risky new trend where men are inflating their balls

While it might seem extreme, men across the country are booking appointments to get Botox and filler injected into their ...